Activity of sorafenib against desmoid tumor/deep fibromatosis

Clinical Cancer Research

Volumn 17, Issue 12, 2011, Pages 4082-4090

  Gounder, Mrinal M ^a   Lefkowitz, Robert A ^a   Keohan, Mary Louise ^a   D'Adamo, David R ^a   Hameed, Meera ^a   Antonescu, Cristina R ^a   Singer, Samuel ^a   Stout, Katherine ^a   Ahn, Linda ^a   Maki, Robert G ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; IMATINIB; LEUPRORELIN; MEDROXYPROGESTERONE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SORAFENIB; SUNITINIB; TAMOXIFEN;

ADOLESCENT; ADULT; ALOPECIA; ALVEOLAR BONE LOSS; ARTICLE; BLURRED VISION; BRACHYTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DESMOID TUMOR; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRY HAND; DRY SKIN; FATIGUE; FEMALE; FIBROMATOSIS; GASTROINTESTINAL SYMPTOM; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMAGE ANALYSIS; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MYOFIBROSIS; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCOTOMA; SKIN BRUISING; SKIN PAIN; TREATMENT DURATION; TRICHODYNIA; VOMITING;

ADOLESCENT; ADULT; BENZENESULFONATES; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROTEIN KINASE INHIBITORS; PYRIDINES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WATCHFUL WAITING; YOUNG ADULT;

EID: 79959219259     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-3322     Document Type: Article

References (22)

1. Fletcher CDM UK, Mertens F. Pathology and genetics of tumours of soft tissue and bone. Lyon, France: IARC Press; 2002.
2. de Bree E, Keus R, Melissas J, Tsiftsis D, van Coevorden F. Desmoid tumors: need for an individualized approach. Expert Rev Anticancer Ther 2009;9:525-35.
3. Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF. The enigma of desmoid tumors. Ann Surg 1999;229:866-72; discussion 872-3.
4. Smith AJ, Lewis JJ, Merchant NB, Leung DH, Woodruff JM, Brennan MF. Surgical management of intra-abdominal desmoid tumours. Br J Surg 2000;87:608-13. (Pubitemid 30261097)
5. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999;17:158-67. (Pubitemid 29022389)
6. Baumert BG, Spahr MO, Von Hochstetter A, Beauvois S, Landmann C, Fridrich K, et al. The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiat Oncol 2007;2:12.
7. Deyrup AT, Tretiakova M, Montag AG. Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases. Cancer 2006;106:208-13. (Pubitemid 43032567)
8. Constantinidou A, Jones RL, Scurr M, Al-Muderis O, Judson I. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer 2009;45:2930-4.
9. Pires de Camargo V, Keohan ML, D'Adamo DR, Antonescu CR, Brennan MF, Singer S, et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer 2010;116:2258-65.
10. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer 1993;72:3244-7. (Pubitemid 23356767)
11. Gega M, Yanagi H, Yoshikawa R, Noda M, Ikeuchi H, Tsukamoto K, et al. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 2006;24:102-5. (Pubitemid 46630500)
12. Patel SR, Benjamin RS. Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol 2006;24:11-2. (Pubitemid 46630487)
13. Weiss AJ, Horowitz S, Lackman RD. Therapy of desmoid tumors and fibromatosis using vinorelbine. Am J Clin Oncol 1999;22:193-5. (Pubitemid 30263353)
14. Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, et al. Efficacy of imatinib in aggressive fibromatosis: results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial. Clin Cancer Res 2010;16:4884-91.
15. Heinrich MC, Joensuu H, Demetri GD, Corless CL, Apperley J, Fletcher JA, et al. Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases. Clin Cancer Res 2008;14:2717-25.
16. Heinrich MC, McArthur GA, Demetri GD, Joensuu H, Bono P, Herrmann R, et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 2006;24:1195-203. (Pubitemid 46638818)
17. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 1997;151:329-34. (Pubitemid 27330053)
18. Davies DR, Armstrong JG, Thakker N, Horner K, Guy SP, Clancy T, et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995;57:1151-8.
19. Amary MF, Pauwels P, Meulemans E, Roemen GM, Islam L, Idowu B, et al. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol 2007;31:1299-309. (Pubitemid 47329665)
20. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 2007;25:1753-9. (Pubitemid 46797957)
21. Sundaram M, McGuire MH, Schajowicz F. Soft-tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images. AJR Am J Roentgenol 1987;148:1247-50. (Pubitemid 17083102)
22. Stacchiotti S, Collini P, Messina A, Morosi C, Barisella M, Bertulli R, et al. High-grade soft-tissue sarcomas: tumor response assessment-pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology 2009;251:447-56.